If you’ve been following regulatory developments this year, you know something significant is happening. NIH recently launched the Standardized Organoid Modeling (SOM) Center with $87 million in funding, and FDA released its roadmap to reduce animal testing in preclinical studies. These aren’t just policy announcements – they’re signals that organoid technology has moved from “promising alternative” to “essential methodology.”
Regulatory bodies are actively encouraging these approaches, and Lambda Biologics is making them more accessible. We’re offering up to 30% savings on our organoid services and assays through February 28, 2026 – because adopting better science shouldn’t strain your budget.
Promotion Period
Offer valid through February 28, 2026, 23:59 CET
Applicable Services
Our promotion offers tailored discounts across a range of organoid services, including organoid-based assays, disease modeling projects, oncology solutions, custom research, technical services (molecular biology, bioinformatics, spatial biology, imaging), and OECD guideline-compliant cosmetics testing. For detailed information on the promotion for each service category, please contact the Lambda Biologics team at info@lambdabiologics.com
Discount
Receive up to 30% off eligible services. Final discount depends on project scope and service type, applied to standard list prices.
Eligibility & Booking
- Valid for new projects only
- Quote requests must be submitted by February 28, 2026
- Projects must be contracted by February 28, 2026 (execution may extend beyond this date)
Cannot be combined with other offers - Services already under contract or previously quoted are not eligible
- Minimum project values may apply for certain discount tiers
Capacity & Availability
All projects are subject to capacity and technical feasibility assessments. Promotional pricing applies to the initial project scope only. We recommend early booking to secure your preferred timeline. Lambda Biologics reserves the right to adjust schedules based on current workload.
General Terms
Lambda Biologics reserves the right to modify or terminate this promotion with reasonable notice. All projects remain subject to Lambda Biologics’ standard terms and conditions, and we reserve the right to verify budget availability for 2025 fund utilization.
Ready to Get Started?
Contact us for project-specific details and personalized quotes: info@lambdabiologics.com
Invest Less. Discover More. Promotion ends February 28, 2026.
Unlocking Human Insight with Organoid Models
Lambda Biologics provides advanced organoid technology and services for biomedical research and drug development. We specialize in physiologically relevant 3D organoid models that bridge the gap between traditional cell cultures and animal models.
Our comprehensive solutions span disease modeling, drug screening, personalized medicine, and regulatory-compliant testing – supporting pharmaceutical companies, biotech firms, academic institutions, and cosmetics manufacturers worldwide.
Cerebral Organoid | Midbrain Organoid | Skin & Hair Organoid | Intestine Organoid | Gastric Cancer Organoid | Breast Cancer Organoid | Hepatocarcinoma Cancer Organoid | Pancreatic Cancer Organoid
